health_text_en

ALZHEIMER’S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important  advancement in Alzheimer’s research and treatment. The full Phase 3 data was reported at the Alzheimer’s Association International Conference® (AAIC®) 2023, in Amsterdam, Netherlands, and online. The data were simultaneously published in the Journal of the American…

thaipr.net

18 ก.ค. 66

ICBA: Aspartame safe, reaffirm WHO and FAO

Aspartame-sweetened foods and beverages are safe, according to a definitive new finding issued jointly today (Thursday) by the World Health Organization (WHO) and the UN Food and Agriculture Organization (FAO). The WHO and FAO Joint Expert Committee on Food Additives (JECFA) reviewed decades of high-quality evidence and real-world consumption data, establishing an Acceptable Daily Intake (ADI) […]

thaipr.net

14 ก.ค. 66

Kexing Biopharm Makes it into China’s Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years

Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized on June 27 as one of “China’s Top 20 Biopharmaceutical Enterprises” (blood products, vaccines and insulin) for two consecutive years. This prestigious sub-list is part of the renowned “2022 China’s Top 100 Pharmaceutical Enterprises”. Kexing Biopharmaceutical’s inclusion can be attributed to its robust research…

thaipr.net

10 ก.ค. 66

Lifera and CENTOGENE, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing

CENTOGENE N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF), have announced a strategic collaboration with the formation of a Joint Venture (JV) to increase local and regional access and rapid delivery of world-class multiomic testing to patients […]

thaipr.net

3 ก.ค. 66

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment of primary hypertension (NCT02901704). The study was led by […]

thaipr.net

30 มิ.ย. 66

Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility

The Society of Human Reproduction and Embryology (ESHRE) annual meeting witnessed a historic event as people from around the globe gathered both in person and online to set a new world record for the most people consuming a dose of inositol simultaneously. The record-breaking event aimed to raise awareness about non-pharmacological options for managing polycystic […]

thaipr.net

29 มิ.ย. 66

Nasdaq Bid Price Deficiency Letter

On June 14, 2023, Etao International Co., Ltd. (the “Company”) received a bid price deficiency letter from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that listed securities to maintain a minimum bid price of $1 per share. Based upon the closing bid price for the last 30 consecutive business days, the Company no […]

thaipr.net

23 มิ.ย. 66

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end users demand…

thaipr.net

22 มิ.ย. 66

Anthem Biosciences Partners with Veeva to Drive Quality Excellence

Leading CDMO streamlining quality management to accelerate the availability of new medicines Veeva Systems (NYSE: VEEV) today announced that fast-growing contract development and manufacturing organization (CDMO) Anthem Biosciences has selected Veeva Vault Quality Suite as the digital foundation to drive quality excellence across its research and manufacturing facilities. With Vault Quality Suite, Anthem Biosciences will have connected systems…

thaipr.net

22 มิ.ย. 66

NABR Files Petition Challenging the Listing of Long-Tailed Macaque by the IUCN

Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed a petition today with the International Union for Conservation of Nature (IUCN) challenging the recent designation of the long-tailed macaque (Cynomolgus macaque) as endangered under IUCN listing criteria. This designation is a result of improperly used data that do not support species […]

thaipr.net

16 มิ.ย. 66
1 … 9 10 11 12 13 … 73

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.